SET Binding Protein 1 (SETBP1) (Middle Region) antibody

Details for Product No. ABIN501780
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Antigen
Synonyms SETBP1, SEB, C130092E12, Seb, mKIAA0437
Epitope
Middle Region
(2), (1), (1)
Reactivity
Human
(16), (12), (12), (12), (12), (12), (12)
Host
Rabbit
(14), (2)
Clonality
Polyclonal
Conjugate
Un-conjugated
(1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1)
Application
Western Blotting (WB)
(10), (7), (3), (2)
Pubmed 1 reference available
Quantity 50 μg
Options
Shipping to United States (Change)
Availability Will be delivered in 2 to 3 Business Days
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Catalog No. ABIN501780
289.00 $
Plus shipping costs $45.00

Order hotline:

  • +1 404 474 4654
  • +1 888 205 9894 (TF)
Immunogen Synthetic peptide directed towards the middle region of human SETBP1
Sequence TPRGGKRKHK PQAPAQPPQQ SPPQQPLPQE EEVKAKRQRK SRGSESEVLP
Predicted Reactivity Bovine : 92 %, Horse : 92 %, Pig : 92 %, Rabbit : 92 %, Mouse : 72 %, Rat : 72 %
Characteristics This is a rabbit polyclonal antibody against SETBP1. It was validated on Western Blot using a cell lysate as a positive control.
Purification Affinity Purified
Alternative Name SETBP1
Background The function of this protein remains unknown.
Molecular Weight 170 kDa
Gene ID 26040
NCBI Accession NP_056374, NM_015559
UniProt Q9Y6X0
Research Area Cancer
Application Notes Optimal working dilutions should be determined experimentally by the investigator.
Comment

Antigen size: 1542 AA

Restrictions For Research Use only
Format Lyophilized
Reconstitution Add 50 µL of distilled water.
Concentration 1 mg/mL
Buffer PBS buffer with 2 % sucrose
Handling Advice Avoid repeated freeze-thaw cycles.
Storage -20 °C
Storage Comment For longer periods of storage, store at -20 °C
Background publications Ott, Schmidt, Schwarzwaelder et al.: "Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1." in: Nature medicine, Vol. 12, Issue 4, pp. 401-9, 2006 (PubMed).

Validation Images
Did you look for something else?
back to top